Biomea Fusion, Inc. (BMEA) — 10-Q Filings

10-Q Filings (6)

• Biomea Fusion Narrows Q3 Loss Amidst R&D Cost Cuts — Nov 4, 2025 Risk: high
  Biomea Fusion, Inc. (BMEA) reported a net loss of $16.407 million for the three months ended September 30, 2025, a significant improvement from the $32.787 mill
• Biomea Fusion's Q2 Loss Widens Amid R&D Surge — Aug 5, 2025 Risk: high
  Biomea Fusion, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its clinical-stage status. The company's net loss for
• Biomea Fusion Files Q1 2025 10-Q — May 5, 2025 Risk: medium
  Biomea Fusion, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position, including common stock and additional p
• Biomea Fusion Files Q3 2024 10-Q — Oct 29, 2024 Risk: medium
  Biomea Fusion, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quar
• Biomea Fusion Files Q2 2024 10-Q — Jul 31, 2024 Risk: medium
  Biomea Fusion, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates. Key financial data inc
• Biomea Fusion, Inc. Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: low
  Biomea Fusion, Inc. (BMEA) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Biomea Fusion, Inc. filed a 10-Q report for the period ending March 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX